SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is experiencing high volatility as investors weigh stronger-than-expected revenue guidance against the company's decision to launch a 75 million share offering. Community discussion is sharply divided between long-term supporters viewing the capital raise as a necessary step to secure government manufacturing loans and frustrated traders criticizing management for diluting shares and stalling positive price momentum.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is experiencing a sharp surge in price driven by a strategic 380-megawatt clean power agreement for data centers and the securing of a non-dilutive $49 million financing package from the U.S. Export-Import Bank. The community is actively discussing the stock's transition into momentum mode, with long-term shareholders debating whether this growth signals a sustained reversal or a familiar cycle of dilution and volatility.

Penguin Solutions, Inc. engages in designing, building, and managing enterprise solutions. It operates through the following segments: Advanced Computing, Integrated Memory, and Optimized LED. The Advanced Computing segment offers platform solutions and services for artificial intelligence, high-performance computing, machine learning, advanced modeling, and the internet of things. The Integrated Memory refers to integrated memory solutions through the design and development. The Optimized LED segment comprises a broad portfolio of application-optimized LEDs. The company was founded in 1988 and is headquartered in Fremont, CA.

Penguin Solutions Inc.

Penguin Solutions is surging as investors react to a significant earnings beat and raised guidance, highlighting the company's growing role as a critical partner in the AI infrastructure and memory stack. Community sentiment is high, with active discussions focused on its strategic positioning within the NVIDIA ecosystem and the potential for a sustained multi-year growth cycle.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as momentum builds around its GLP-1/GIP obesity pipeline, with community members actively discussing a potential buyout or major partnership as institutional accumulation appears to intensify. Investors are eagerly front-running key upcoming clinical data readouts, fueling speculation about the stock's ability to challenge its 52-week highs and capture significant market share.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is seeing intense community speculation and active trading volume driven by persistent buyout rumors and strategic shifts, including the closure of its internal discovery center to focus on capital-efficient partnerships. Traders are closely monitoring short interest and recent technical momentum, as investors weigh potential M&A scenarios against the company's long-term commercial execution.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is gaining significant momentum as investors anticipate the final Phase 3 durability data for its COMP360 treatment, which is critical for an upcoming FDA NDA submission. The community is actively debating the stock's potential for a major re-rating, fueled by recent board appointments, executive-level optimism about commercialization, and the broader institutional rotation into biotech stocks with significant clinical catalysts.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster is gaining strong market momentum as it secures federal compliance under the Build America, Buy America Act, enabling its Rev8 lidar sensors to be deployed across critical U.S. infrastructure projects. Community discussions are highly bullish, with many investors focusing on the company's deepening integration into the physical AI and robotics supply chain through strategic partnerships, viewing recent volatility as a healthy consolidation before a potential move toward higher valuation targets.

Vera Therapeutics, Inc. is a clinical stage biotechnical company which engages in the development and commercialization of transformative treatments for immunological diseases. The company was founded by Marshall Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is trending following the FDAs accelerated approval of its lead drug, TRUTAKNA (atacicept), for the treatment of adults with primary IgA nephropathy. While the community is debating the muted post-approval price action, investors remain focused on the drug's commercial potential as the first dual BAFF/APRIL inhibitor in a competitive market.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is attracting significant attention as investors react to its new joint manufacturing venture with Toyota and ongoing FAA certification progress for its electric air taxi. The community is actively debating the stock's potential as a long-term asymmetric play while navigating volatility, with many traders focused on critical support levels and the company's capital runway as it pushes toward commercialization.

American Bitcoin Corp. engages in the management of a bitcoin accumulation platform. It offers exposure to bitcoin through an industry-first business model that integrates scaled self-mining operations with disciplined accumulation strategies. The company was founded by Eric Trump and Donald John Trump Jr. on October 3, 2018 and is headquartered in Miami, FL.

American Bitcoin Corp. - Ordinary Shares - Class A

American Bitcoin Corp.

American Bitcoin Corp. is experiencing intense community scrutiny and volatility, driven by a proposed reverse stock split and ongoing debates regarding the company's association with the Trump family and its financial management. Investors are actively discussing the stock's significant decline from its highs, questioning the firm's operational transparency, and debating the potential impact of legislative developments like the Clarity Act on its future performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AMAT Stock Rises 284% From Its 52-Week Low: Should You Buy Now?

After a 284% rebound from its 52-week low, Applied Materials still has AI-driven demand, portfolio breadth and earnings momentum supporting further growth.

Is KLA Corporation (KLAC) One of the Best Stocks on the Rise to Invest In?

Is KLA Corporation (KLAC) One of the Best Stocks on the Rise to Invest In...

Vltava Fund Exited KLA Corporation (KLAC) Amid Price-Quality Imbalance

Vltava Fund Exited KLA Corporation (KLAC) Amid Price-Quality Imbalance...

KLA (KLAC) Stock Moves -11.51%: What You Should Know

KLA (KLAC) reached $235.55 at the closing of the latest trading day, reflecting a -11.51% change compared to its last close.

Here's How Much You Would Have Made Owning KLA Stock In The Last 5 Years

KLA (NASDAQ:KLAC) has outperformed the market over the past 5 years by 39.22% on an annualized basis producing an average annual return of 50.7%. Currently, KLA has a market capitalization of $316.04 billion.
Buyingread more...

ONTO Stock Climbs 26% in a Month: What's the Next Move for Investors?

Onto Innovation's 25.5% rally reflects AI-led demand, advanced packaging gains and new product momentum, but rich valuation raises questions about the next move.

COHU Stock Outlook Hinges on AI Growth and Profit Recovery

Cohu's AI and HPC opportunities are growing, but the stock outlook still hinges on execution, HBM traction and stronger profitability follow-through.

Can AI Demand Help Lam Research Hit New Highs for Gross Margin in Q4?

LRCX's AI-fueled demand for advanced memory, foundry and packaging tools could push Q4 gross margin above 50% for the first time.

ASE Technology vs. Amkor: Which Chip Packaging Stock Is the Better Buy?

Is ASX stock the better buy over AMKOR as AI packaging momentum, stronger earnings growth and lower valuation give it an edge?

Can KLAC Keep Outgrowing the Wafer Equipment Market Through 2027?

KLA's AI-driven demand, process-control leadership and advanced packaging exposure may help it outgrow the WFE market through 2027.

KLA Corp. engages in the supply of process control and yield management solutions for the semiconductor and related nano-electronics industries. The company operates through the following segments: Semiconductor Process Control, Specialty Semiconductor Process, and PCB, Display and Component Inspection. The Semiconductor Process Control segment provides a comprehensive portfolio of inspection, metrology and data analytics products and related services. The Specialty Semiconductor Process segment develops and sells advanced vacuum deposition and etching process tools. The PCB, Display and Component Inspection segment enables electronic device manufacturers to inspect, test and measure PCBs, flat panel displays and ICs to verify their quality. Its products include manufactured chips, reticle, packaging, surface profilers, nanochemical testers, KT pro equipment, and compound semiconductors. The company was founded on July 9, 1975 and is headquartered in Milpitas, CA.

KLA Corp.

KLAC Stock Is Falling Today Despite Q2 Beat And Slew Of Price Target Hikes – Wall Street Explains What’s Going On

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '26	$1.00	--	--	N/A
Q3 '26	$9.17	$0.94	-89.75%	MISSED
Q2 '26	$8.79	$8.85	0.67%	BEAT
Q1 '26	$8.63	$8.81	2.14%	BEAT
Q4 '25	$8.56	$9.38	9.61%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

KLACKLA Corp.

Upcoming Earnings: Q4 '26

Historical Earnings

Latest KLAC News